Published in Pharma Law Weekly, January 11th, 2005
CombiMatrix and NDC have a strategic alliance to discover and develop new nanomaterials, nanotechnology tools, and associated intellectual property. CombiMatrix has licensed its semiconductor microarray technology exclusively to NDC for use in NDC's combinatorial nanomaterials discovery efforts for applications that include fuel cell catalysts, materials for rechargeable batteries, and electro-optic materials for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.